Skip to main content
Caplight Logo









Plantik Biosciences

Plantik Biosciences

Private
ParisHealthcare & Life Scienceshttps://plantik.bio

Last Round

Accelerator

Nov 13, 2024

Total Funding Raised

$2.1M

Company Overview

Plantik Biosciences operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was an Accelerator round in November 2024.

Plantik Biosciences is an agritech company that develops climate-resilient crops using next-generation plant engineering and genome-editing technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Plantik Biosciences Comparables

Compare Plantik Biosciences with similar companies based on industry and business-model similarity.

Plantik Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phytoform Labs
84%
Heritable Agriculture
82%
Resurrect bio
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Plantik Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 13, 2024
SeedFeb 6, 2024
GrantSep 13, 2022
AcceleratorJan 5, 2022
AcceleratorSep 10, 2020
Accelerator
Apr 8, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ying Shao

Co-Founder & CEO

Founding Team

For institutional investors. Book with your work email.

Plantik Biosciences Investors

Notable investors and investment history

Book a demo to see all 10 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 96% MoM.

  • Feb 19, 2026

    Grew 50% QoQ from 6 to 9 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • partners_withSep 28, 2026

    Plantik and Hudson River partnered to de-risk heat-tolerant strawberries, aiming to produce a validated heat-tolerance trait that any strawberry breeder can license, on Sep 28th '26.

  • is_developingSep 28, 2026

    Plantik and Hudson River Biotechnology are partnering to develop heat tolerance in crops, combining heat-tolerant targets identified in tomatoes with transgene-free strawberry genome-editing methods, with validation trials already underway and the goal of producing a licensable trait for strawberry breeders.

Book a demo to see all news

For institutional investors. Book with your work email.

Plantik Biosciences Filings

Explore SEC and related filing metadata, where available.

Plantik Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Plantik Biosciences's valuation, stock price, and market status.

Is Plantik Biosciences a public or private company?

Plantik Biosciences is a private company.

What is the current stock price of Plantik Biosciences?

Plantik Biosciences is a private company, so its shares have no public market price. Caplight tracks Plantik Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Plantik Biosciences worth (valuation)?

Valuation information for Plantik Biosciences is not publicly available.

Can I buy Plantik Biosciences stock?

Plantik Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Plantik Biosciences's last funding round?

Plantik Biosciences's most recent funding round was Accelerator on November 13, 2024.

Who are the main investors in Plantik Biosciences?

Key investors in Plantik Biosciences include Future Food Fund.

Will Plantik Biosciences IPO soon?

No public IPO plans have been announced for Plantik Biosciences.

How can I track Plantik Biosciences secondary market activity?

Caplight tracks bids, offers, and trades in Plantik Biosciences's shares on secondary markets.

Firmographic Details

HeadquartersParis
Employee Range11
Year Founded2019
Last FundingNov 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?